TCL Archive Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs July 29, 1983
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive Senate Vote On Override Of NIH Reauthorization Veto Delayed Until After US-USSR Summit Meeting November 22, 1985
